St. Jude Medical, Inc. (STJ) Tops Q3 EPS by 2c; Guides Q4 Below the Street
Tweet Send to a FriendGet Alerts STJ Hot Sheet
Price: $45.70 --0%
EPS Growth %: +7.0%
Financial Fact:
Selling, general and administrative expense: 468M
Today's EPS Names:
SFL, RL, PERY, More
EPS Growth %: +7.0%
Financial Fact:
Selling, general and administrative expense: 468M
Today's EPS Names:
SFL, RL, PERY, More
Trade STJ Now!
St. Jude Medical, Inc. (NYSE: STJ) reported Q3 EPS of $0.78, $0.02 better than the analyst estimate of $0.76. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.37 billion.
St. Jude Medical, Inc. sees Q4 2011 EPS of $0.83-$0.85, versus the consensus of $0.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
St. Jude Medical, Inc. sees Q4 2011 EPS of $0.83-$0.85, versus the consensus of $0.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Petsmart, Inc. (PETM) Tops Q1 EPS by 2c; Boosts FY13 Outlook
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
